Search Within

Stephen D Nimer

  1. "2002"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (7)
Groups
  1. Department of Medicine (20)
  2. Hematologic Malignancies, Division of (20)
  3. Center for Hematologic Malignancies (5)
  4. Lymphoma (3)
  5. Adult Leukemia (2)
  6. Cell Biology Program Faculty (2)

More Groups

People
  1. Jorg Cammenga (4)
  2. Tarun Kewalramani (4)
  3. Andrew Zelenetz (3)
  4. Craig Moskowitz (3)
  5. Jing Qin (3)
  6. Piernicola Boccuni (3)

More People

Years
  1. 2002 (20)
Publications
  1. Blood (15)
  2. Experimental Hematology (1)
  3. Human Pathology (1)
  4. Immunity (1)
  5. Leukemia Research (1)
  6. Oncogene (1)
Publishers
  1. American Society of Hematology (15)
  2. Cell Press (1)
  3. Elsevier Inc. (1)
  4. Elsevier Ltd (1)
  5. Elsevier Science, Inc. (1)
  6. Nature Publishing Group (1)

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An analysis of accelerated full course chemotherapy followed by upfront high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for patients with International Prognostic Index IV (IPI IV) aggressive NHL
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Donnelly, G.; Zelenetz, A. D.; Noy, A.; Rice, D.; Kuznetsov, M.; Straus, D.; Nimer, S. D.; Portlock, C. S.
    Blood (2002)

    Fulltext@MSK | Save
  • Similar outcomes for chemosensitive (CS) relapsed or primary refractory peripheral T-cell lymphoma (PTCL) and diffuse large B-cell lymphoma (DLBCL) treated with autologous transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S.; Qin, J.; Malhotra, S.; Yahalom, J.; Moskowitz, C. H.
    Blood (2002)

    Fulltext@MSK | Save
  • Ig V-H and V-L patient-specific PCR: Assessing clonotypic contamination in stem cell components (SCC) mobilized with melphalan in myeloma
    Meeting Abstract

    Zhou, P.; Zhang, Y.; Martinez, C.; Kalakonda, N.; Nimer, S. D.; Comenzo, R. L.
    Blood (2002)

    Fulltext@MSK | Save
  • Sodium salicylate induces G1 arrest and differentiation and inhibits Cdk2 activity in TF-1 cells without inhibiting NF-kappa B
    Meeting Abstract

    Sokolic, R.; Klampfer, L.; Jackson, G.; Nimer, S.
    Blood (2002)

    Fulltext@MSK | Save
  • Autologous transplantation (ASCT) with total body irradiation (TBI) based conditioning appears superior to chemotherapy only (Non-TBI) conditioning for patients with relapsed or primary refractory chemosensitive (CS) diffuse large B-cell lymphoma (DLBCL) who have no extranodal sits (ENS) of disease (dz)
    Meeting Abstract

    Kewalramani, T.; Moskowitz, C. H.; Zelenetz, A. D.; Malhotra, S.; Qin, J.; Yahalom, J.; Nimer, S. D.
    Blood (2002)

    Fulltext@MSK | Save
  • Results of autologous stem cell transplantation (SCT) following stem cell mobilization with melphalan in myeloma patients
    Meeting Abstract

    Comenzo, R. L.; Costello, S.; Reich, L.; Drake, L.; Zhou, P.; Martinez, C.; Klimek, V.; Kewalramani, T.; Osman, K.; Dhodapkar, M.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • A "first in man" study of the safety and PK/PD of an oral FLT3 inhibitor (MLN518) in patients with AML or high risk myelodysplasia
    Meeting Abstract

    Heinrich, M. C.; Druker, B. J.; Curtin, P. T.; Paquette, R.; Sawyers, C. L.; De Angelo, D. J.; Gilliland, G. D.; Stone, R. M.; Caliguiri, M. A.; Byrd, J. C.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • TGF beta induced growth arrest of human hematopoietic cells requires p57KIP2 upregulation
    Meeting Abstract

    Scandura, J. M.; Boccuni, P.; Nimer, S. D.
    Blood (2002)

    Fulltext@MSK | Save
  • Expression and structural integrity of the H-l(3)mbt polycomb group gene in myeloid malignancies and myeloproliferative diseases associated with 20q
    Meeting Abstract

    Macgrogan, D.; Alvarez, S.; Kalakonda, N.; Deblasio, T.; Boccuni, P.; Nimer, S. D.
    Blood (2002)

    Fulltext@MSK | Save
  • PKC412, an oral FLT3 inhibitor, has activity in mutant FLT3 acute myeloid leukemia (AML): A phase II clinical trial
    Meeting Abstract

    Stone, R. M.; Klimek, V.; DeAngelo, D. J.; Nimer, S.; Estey, E.; Galinsky, I.; Neuberg, D.; Yap, A.; Fox, E. A.; Gilliland, D. G.; more...
    Blood (2002)

    Fulltext@MSK | Save